SOURCE: Inforsense, Ltd.

September 18, 2007 09:00 ET

University of British Columbia Selects InforSense GenSense for Genomic Studies and Bioinformatics

iCAPTURE Research Centre to Use InforSense Workflow-based Analytics for Genetic Research Program

LONDON and CAMBRIDGE, MA--(Marketwire - September 18, 2007) - InforSense Ltd., the leading provider of embedded enterprise intelligence, today announced that the University of British Columbia's (UBC) James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, based at St. Paul's Hospital (part of Providence Health Care), Vancouver, British Columbia, has selected InforSense GenSense to support its genetic research programs into heart, lung and vascular systems.

"The volume of data being generated by the latest genotyping technologies is very large and growing exponentially, and we require a tool that scales to automatically check and analyze these large data sets," said Scott Tebbutt, PhD, Principal Investigator & Assistant Professor at the James Hogg iCAPTURE Centre. "GenSense provides us with workflows and an easy-to-use portal that rapidly QCs and annotates the data, enabling us to quickly gain maximum value from our genome studies."

"We are delighted to work with UBC's iCAPTURE Centre to leverage GenSense within their research programs," said Joseph F. Donahue, Senior Vice President at InforSense. "GenSense provides comprehensive functionality out-of-the-box, and because it is based on the InforSense platform, customers can easily modify their workflows to meet new requirements in this emerging and fast-paced research area."

The iCAPTURE Centre

The James Hogg iCAPTURE Centre (Imaging, Cell Analysis, and Phenotyping Toward Understanding Responsive, Reparative, Remodelling, and Recombinant Events) at St. Paul's Hospital is a UBC Senate-approved research centre supported collaboratively by the Faculty of Medicine of UBC and Providence Health Care. Built on a 30-year history of research excellence, the iCAPTURE Centre was created in 2000 with the infusion of $21 million of infrastructure funding from the Canada Foundation for Innovation and its partners.

St. Paul's Hospital

As a University of British Columbia teaching hospital, St. Paul's serves as a training facility for cardiac professionals and is a leader in heart disease research, both in the laboratory and in the clinic. Innovators in clinical care are engaged in applied research throughout the Heart Centre. Recent examples include the development of a wireless implantable defibrillator.

InforSense GenSense

InforSense GenSense enables the analysis of data from the latest generation of genotyping platforms. It has been specifically designed to help researchers understand complex analyses, quickly find interesting SNPs and produce reports with easy to understand graphical summaries and interactive visualizations of large data sets. GenSense has achieved GeneChip-compatible™ status with the Affymetrix GeneChip® microarray platform and also supports data from Illumina and other standard genomics data sources such as Entrez Gene, HapMap and dbSNPs.

About InforSense

InforSense Ltd., the leader in embedded enterprise analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical and biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies are using the company's flagship product, InforSense, to enhance productivity by embedding analytics within their business processes. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

For more information visit www.inforsense.com.

InforSense and the InforSense logo are registered trademarks of InforSense Limited. GenSense is a trademark of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.

Contact Information

  • Contact:
    Lisa Allocca
    Red Javelin Communications, Inc.
    978-470-2227
    Email Contact